ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
  • Category
  • Region
U.S. (TOLL FREE)
+1 (315) 215-3225
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Tofacitinib Citrate API Market Research Report 2025
Published Date: February 2025
|
Report Code: QYRE-Auto-24K11329
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Tofacitinib Citrate API Market Research Report 2022
BUY CHAPTERS

Global Tofacitinib Citrate API Market Research Report 2025

Code: QYRE-Auto-24K11329
Report
February 2025
Pages:115
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Huateng Pharma
Beijing Mesochem Technology
CR Double-Crane Pharmaceuticals
Changzhou Pharmaceutical Factory
Chongqing Fuan Pharmaceutical
Sichuan Renan Pharmaceutical
Metrochem API
Dr. Reddy’s Laboratories
Apotex Pharmachem
Bulat Pharmaceutical
Delmar Chemicals
Glenmark Pharmaceuticals
Kukjeon Pharmaceutical
MSN Laboratories
Mylan NV
Vitalpharms
Kekule Pharma

Tofacitinib Citrate API Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Tofacitinib Citrate API Market

Tofacitinib Citrate API Market

The global market for Tofacitinib Citrate API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Tofacitinib Citrate API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tofacitinib Citrate API.
The Tofacitinib Citrate API market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Tofacitinib Citrate API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tofacitinib Citrate API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Tofacitinib Citrate API Market Report

Report Metric Details
Report Name Tofacitinib Citrate API Market
CAGR 5%
by Type
  • 0.98
  • 0.99
  • Others
by Application
  • Tablets
  • Others
Production by Region
  • North America
  • Europe
  • China
  • Japan
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Huateng Pharma, Beijing Mesochem Technology, CR Double-Crane Pharmaceuticals, Changzhou Pharmaceutical Factory, Chongqing Fuan Pharmaceutical, Sichuan Renan Pharmaceutical, Metrochem API, Dr. Reddy's Laboratories, Kekule Pharma, Apotex Pharmachem, Bulat Pharmaceutical, Delmar Chemicals, Glenmark Pharmaceuticals, Kukjeon Pharmaceutical, MSN Laboratories, Mylan Inc, Vitalpharms
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Tofacitinib Citrate API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Production/output, value of Tofacitinib Citrate API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
  • Chapter 4: Consumption of Tofacitinib Citrate API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 10: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Tofacitinib Citrate API Market report?

Ans: The main players in the Tofacitinib Citrate API Market are Huateng Pharma, Beijing Mesochem Technology, CR Double-Crane Pharmaceuticals, Changzhou Pharmaceutical Factory, Chongqing Fuan Pharmaceutical, Sichuan Renan Pharmaceutical, Metrochem API, Dr. Reddy's Laboratories, Kekule Pharma, Apotex Pharmachem, Bulat Pharmaceutical, Delmar Chemicals, Glenmark Pharmaceuticals, Kukjeon Pharmaceutical, MSN Laboratories, Mylan Inc, Vitalpharms

What are the Application segmentation covered in the Tofacitinib Citrate API Market report?

Ans: The Applications covered in the Tofacitinib Citrate API Market report are Tablets, Others

What are the Type segmentation covered in the Tofacitinib Citrate API Market report?

Ans: The Types covered in the Tofacitinib Citrate API Market report are 0.98, 0.99, Others

1 Tofacitinib Citrate API Market Overview
1.1 Product Definition
1.2 Tofacitinib Citrate API by Type
1.2.1 Global Tofacitinib Citrate API Market Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 0.98
1.2.3 0.99
1.2.4 Others
1.3 Tofacitinib Citrate API by Application
1.3.1 Global Tofacitinib Citrate API Market Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Tablets
1.3.3 Others
1.4 Global Market Growth Prospects
1.4.1 Global Tofacitinib Citrate API Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Tofacitinib Citrate API Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Tofacitinib Citrate API Production Estimates and Forecasts (2020-2031)
1.4.4 Global Tofacitinib Citrate API Market Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Tofacitinib Citrate API Production Market Share by Manufacturers (2020-2025)
2.2 Global Tofacitinib Citrate API Production Value Market Share by Manufacturers (2020-2025)
2.3 Global Key Players of Tofacitinib Citrate API, Industry Ranking, 2023 VS 2024
2.4 Global Tofacitinib Citrate API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Tofacitinib Citrate API Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Tofacitinib Citrate API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Tofacitinib Citrate API, Product Offered and Application
2.8 Global Key Manufacturers of Tofacitinib Citrate API, Date of Enter into This Industry
2.9 Tofacitinib Citrate API Market Competitive Situation and Trends
2.9.1 Tofacitinib Citrate API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Tofacitinib Citrate API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Tofacitinib Citrate API Production by Region
3.1 Global Tofacitinib Citrate API Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Tofacitinib Citrate API Production Value by Region (2020-2031)
3.2.1 Global Tofacitinib Citrate API Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Tofacitinib Citrate API by Region (2026-2031)
3.3 Global Tofacitinib Citrate API Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Tofacitinib Citrate API Production Volume by Region (2020-2031)
3.4.1 Global Tofacitinib Citrate API Production by Region (2020-2025)
3.4.2 Global Forecasted Production of Tofacitinib Citrate API by Region (2026-2031)
3.5 Global Tofacitinib Citrate API Market Price Analysis by Region (2020-2025)
3.6 Global Tofacitinib Citrate API Production and Value, Year-over-Year Growth
3.6.1 North America Tofacitinib Citrate API Production Value Estimates and Forecasts (2020-2031)
3.6.2 Europe Tofacitinib Citrate API Production Value Estimates and Forecasts (2020-2031)
3.6.3 China Tofacitinib Citrate API Production Value Estimates and Forecasts (2020-2031)
3.6.4 Japan Tofacitinib Citrate API Production Value Estimates and Forecasts (2020-2031)
4 Tofacitinib Citrate API Consumption by Region
4.1 Global Tofacitinib Citrate API Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Tofacitinib Citrate API Consumption by Region (2020-2031)
4.2.1 Global Tofacitinib Citrate API Consumption by Region (2020-2025)
4.2.2 Global Tofacitinib Citrate API Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Tofacitinib Citrate API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Tofacitinib Citrate API Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Tofacitinib Citrate API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Tofacitinib Citrate API Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Tofacitinib Citrate API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Tofacitinib Citrate API Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Tofacitinib Citrate API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa Tofacitinib Citrate API Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Tofacitinib Citrate API Production by Type (2020-2031)
5.1.1 Global Tofacitinib Citrate API Production by Type (2020-2025)
5.1.2 Global Tofacitinib Citrate API Production by Type (2026-2031)
5.1.3 Global Tofacitinib Citrate API Production Market Share by Type (2020-2031)
5.2 Global Tofacitinib Citrate API Production Value by Type (2020-2031)
5.2.1 Global Tofacitinib Citrate API Production Value by Type (2020-2025)
5.2.2 Global Tofacitinib Citrate API Production Value by Type (2026-2031)
5.2.3 Global Tofacitinib Citrate API Production Value Market Share by Type (2020-2031)
5.3 Global Tofacitinib Citrate API Price by Type (2020-2031)
6 Segment by Application
6.1 Global Tofacitinib Citrate API Production by Application (2020-2031)
6.1.1 Global Tofacitinib Citrate API Production by Application (2020-2025)
6.1.2 Global Tofacitinib Citrate API Production by Application (2026-2031)
6.1.3 Global Tofacitinib Citrate API Production Market Share by Application (2020-2031)
6.2 Global Tofacitinib Citrate API Production Value by Application (2020-2031)
6.2.1 Global Tofacitinib Citrate API Production Value by Application (2020-2025)
6.2.2 Global Tofacitinib Citrate API Production Value by Application (2026-2031)
6.2.3 Global Tofacitinib Citrate API Production Value Market Share by Application (2020-2031)
6.3 Global Tofacitinib Citrate API Price by Application (2020-2031)
7 Key Companies Profiled
7.1 Huateng Pharma
7.1.1 Huateng Pharma Tofacitinib Citrate API Company Information
7.1.2 Huateng Pharma Tofacitinib Citrate API Product Portfolio
7.1.3 Huateng Pharma Tofacitinib Citrate API Production, Value, Price and Gross Margin (2020-2025)
7.1.4 Huateng Pharma Main Business and Markets Served
7.1.5 Huateng Pharma Recent Developments/Updates
7.2 Beijing Mesochem Technology
7.2.1 Beijing Mesochem Technology Tofacitinib Citrate API Company Information
7.2.2 Beijing Mesochem Technology Tofacitinib Citrate API Product Portfolio
7.2.3 Beijing Mesochem Technology Tofacitinib Citrate API Production, Value, Price and Gross Margin (2020-2025)
7.2.4 Beijing Mesochem Technology Main Business and Markets Served
7.2.5 Beijing Mesochem Technology Recent Developments/Updates
7.3 CR Double-Crane Pharmaceuticals
7.3.1 CR Double-Crane Pharmaceuticals Tofacitinib Citrate API Company Information
7.3.2 CR Double-Crane Pharmaceuticals Tofacitinib Citrate API Product Portfolio
7.3.3 CR Double-Crane Pharmaceuticals Tofacitinib Citrate API Production, Value, Price and Gross Margin (2020-2025)
7.3.4 CR Double-Crane Pharmaceuticals Main Business and Markets Served
7.3.5 CR Double-Crane Pharmaceuticals Recent Developments/Updates
7.4 Changzhou Pharmaceutical Factory
7.4.1 Changzhou Pharmaceutical Factory Tofacitinib Citrate API Company Information
7.4.2 Changzhou Pharmaceutical Factory Tofacitinib Citrate API Product Portfolio
7.4.3 Changzhou Pharmaceutical Factory Tofacitinib Citrate API Production, Value, Price and Gross Margin (2020-2025)
7.4.4 Changzhou Pharmaceutical Factory Main Business and Markets Served
7.4.5 Changzhou Pharmaceutical Factory Recent Developments/Updates
7.5 Chongqing Fuan Pharmaceutical
7.5.1 Chongqing Fuan Pharmaceutical Tofacitinib Citrate API Company Information
7.5.2 Chongqing Fuan Pharmaceutical Tofacitinib Citrate API Product Portfolio
7.5.3 Chongqing Fuan Pharmaceutical Tofacitinib Citrate API Production, Value, Price and Gross Margin (2020-2025)
7.5.4 Chongqing Fuan Pharmaceutical Main Business and Markets Served
7.5.5 Chongqing Fuan Pharmaceutical Recent Developments/Updates
7.6 Sichuan Renan Pharmaceutical
7.6.1 Sichuan Renan Pharmaceutical Tofacitinib Citrate API Company Information
7.6.2 Sichuan Renan Pharmaceutical Tofacitinib Citrate API Product Portfolio
7.6.3 Sichuan Renan Pharmaceutical Tofacitinib Citrate API Production, Value, Price and Gross Margin (2020-2025)
7.6.4 Sichuan Renan Pharmaceutical Main Business and Markets Served
7.6.5 Sichuan Renan Pharmaceutical Recent Developments/Updates
7.7 Metrochem API
7.7.1 Metrochem API Tofacitinib Citrate API Company Information
7.7.2 Metrochem API Tofacitinib Citrate API Product Portfolio
7.7.3 Metrochem API Tofacitinib Citrate API Production, Value, Price and Gross Margin (2020-2025)
7.7.4 Metrochem API Main Business and Markets Served
7.7.5 Metrochem API Recent Developments/Updates
7.8 Dr. Reddy's Laboratories
7.8.1 Dr. Reddy's Laboratories Tofacitinib Citrate API Company Information
7.8.2 Dr. Reddy's Laboratories Tofacitinib Citrate API Product Portfolio
7.8.3 Dr. Reddy's Laboratories Tofacitinib Citrate API Production, Value, Price and Gross Margin (2020-2025)
7.8.4 Dr. Reddy's Laboratories Main Business and Markets Served
7.8.5 Dr. Reddy's Laboratories Recent Developments/Updates
7.9 Kekule Pharma
7.9.1 Kekule Pharma Tofacitinib Citrate API Company Information
7.9.2 Kekule Pharma Tofacitinib Citrate API Product Portfolio
7.9.3 Kekule Pharma Tofacitinib Citrate API Production, Value, Price and Gross Margin (2020-2025)
7.9.4 Kekule Pharma Main Business and Markets Served
7.9.5 Kekule Pharma Recent Developments/Updates
7.10 Apotex Pharmachem
7.10.1 Apotex Pharmachem Tofacitinib Citrate API Company Information
7.10.2 Apotex Pharmachem Tofacitinib Citrate API Product Portfolio
7.10.3 Apotex Pharmachem Tofacitinib Citrate API Production, Value, Price and Gross Margin (2020-2025)
7.10.4 Apotex Pharmachem Main Business and Markets Served
7.10.5 Apotex Pharmachem Recent Developments/Updates
7.11 Bulat Pharmaceutical
7.11.1 Bulat Pharmaceutical Tofacitinib Citrate API Company Information
7.11.2 Bulat Pharmaceutical Tofacitinib Citrate API Product Portfolio
7.11.3 Bulat Pharmaceutical Tofacitinib Citrate API Production, Value, Price and Gross Margin (2020-2025)
7.11.4 Bulat Pharmaceutical Main Business and Markets Served
7.11.5 Bulat Pharmaceutical Recent Developments/Updates
7.12 Delmar Chemicals
7.12.1 Delmar Chemicals Tofacitinib Citrate API Company Information
7.12.2 Delmar Chemicals Tofacitinib Citrate API Product Portfolio
7.12.3 Delmar Chemicals Tofacitinib Citrate API Production, Value, Price and Gross Margin (2020-2025)
7.12.4 Delmar Chemicals Main Business and Markets Served
7.12.5 Delmar Chemicals Recent Developments/Updates
7.13 Glenmark Pharmaceuticals
7.13.1 Glenmark Pharmaceuticals Tofacitinib Citrate API Company Information
7.13.2 Glenmark Pharmaceuticals Tofacitinib Citrate API Product Portfolio
7.13.3 Glenmark Pharmaceuticals Tofacitinib Citrate API Production, Value, Price and Gross Margin (2020-2025)
7.13.4 Glenmark Pharmaceuticals Main Business and Markets Served
7.13.5 Glenmark Pharmaceuticals Recent Developments/Updates
7.14 Kukjeon Pharmaceutical
7.14.1 Kukjeon Pharmaceutical Tofacitinib Citrate API Company Information
7.14.2 Kukjeon Pharmaceutical Tofacitinib Citrate API Product Portfolio
7.14.3 Kukjeon Pharmaceutical Tofacitinib Citrate API Production, Value, Price and Gross Margin (2020-2025)
7.14.4 Kukjeon Pharmaceutical Main Business and Markets Served
7.14.5 Kukjeon Pharmaceutical Recent Developments/Updates
7.15 MSN Laboratories
7.15.1 MSN Laboratories Tofacitinib Citrate API Company Information
7.15.2 MSN Laboratories Tofacitinib Citrate API Product Portfolio
7.15.3 MSN Laboratories Tofacitinib Citrate API Production, Value, Price and Gross Margin (2020-2025)
7.15.4 MSN Laboratories Main Business and Markets Served
7.15.5 MSN Laboratories Recent Developments/Updates
7.16 Mylan Inc
7.16.1 Mylan Inc Tofacitinib Citrate API Company Information
7.16.2 Mylan Inc Tofacitinib Citrate API Product Portfolio
7.16.3 Mylan Inc Tofacitinib Citrate API Production, Value, Price and Gross Margin (2020-2025)
7.16.4 Mylan Inc Main Business and Markets Served
7.16.5 Mylan Inc Recent Developments/Updates
7.17 Vitalpharms
7.17.1 Vitalpharms Tofacitinib Citrate API Company Information
7.17.2 Vitalpharms Tofacitinib Citrate API Product Portfolio
7.17.3 Vitalpharms Tofacitinib Citrate API Production, Value, Price and Gross Margin (2020-2025)
7.17.4 Vitalpharms Main Business and Markets Served
7.17.5 Vitalpharms Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Tofacitinib Citrate API Industry Chain Analysis
8.2 Tofacitinib Citrate API Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Tofacitinib Citrate API Production Mode & Process Analysis
8.4 Tofacitinib Citrate API Sales and Marketing
8.4.1 Tofacitinib Citrate API Sales Channels
8.4.2 Tofacitinib Citrate API Distributors
8.5 Tofacitinib Citrate API Customer Analysis
9 Tofacitinib Citrate API Market Dynamics
9.1 Tofacitinib Citrate API Industry Trends
9.2 Tofacitinib Citrate API Market Drivers
9.3 Tofacitinib Citrate API Market Challenges
9.4 Tofacitinib Citrate API Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
FEATURED COMPANIES
Huateng Pharma
Beijing Mesochem Technology
CR Double-Crane Pharmaceuticals
Changzhou Pharmaceutical Factory
Chongqing Fuan Pharmaceutical
Sichuan Renan Pharmaceutical
Metrochem API
Dr. Reddy’s Laboratories
Apotex Pharmachem
Bulat Pharmaceutical
Delmar Chemicals
Glenmark Pharmaceuticals
Kukjeon Pharmaceutical
MSN Laboratories
Mylan NV
Vitalpharms
Kekule Pharma
List of Tables
 Table 1. Global Tofacitinib Citrate API Market Value by Type, (US$ Million) & (2024 VS 2031)
 Table 2. Global Tofacitinib Citrate API Market Value by Application, (US$ Million) & (2024 VS 2031)
 Table 3. Global Tofacitinib Citrate API Production Capacity (Tons) by Manufacturers in 2024
 Table 4. Global Tofacitinib Citrate API Production by Manufacturers (2020-2025) & (Tons)
 Table 5. Global Tofacitinib Citrate API Production Market Share by Manufacturers (2020-2025)
 Table 6. Global Tofacitinib Citrate API Production Value by Manufacturers (2020-2025) & (US$ Million)
 Table 7. Global Tofacitinib Citrate API Production Value Share by Manufacturers (2020-2025)
 Table 8. Global Key Players of Tofacitinib Citrate API, Industry Ranking, 2023 VS 2024
 Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value in Tofacitinib Citrate API as of 2024)
 Table 10. Global Market Tofacitinib Citrate API Average Price by Manufacturers (US$/Kg) & (2020-2025)
 Table 11. Global Key Manufacturers of Tofacitinib Citrate API, Manufacturing Base Distribution and Headquarters
 Table 12. Global Key Manufacturers of Tofacitinib Citrate API, Product Offered and Application
 Table 13. Global Key Manufacturers of Tofacitinib Citrate API, Date of Enter into This Industry
 Table 14. Global Tofacitinib Citrate API Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 15. Mergers & Acquisitions, Expansion Plans
 Table 16. Global Tofacitinib Citrate API Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 17. Global Tofacitinib Citrate API Production Value (US$ Million) by Region (2020-2025)
 Table 18. Global Tofacitinib Citrate API Production Value Market Share by Region (2020-2025)
 Table 19. Global Tofacitinib Citrate API Production Value (US$ Million) Forecast by Region (2026-2031)
 Table 20. Global Tofacitinib Citrate API Production Value Market Share Forecast by Region (2026-2031)
 Table 21. Global Tofacitinib Citrate API Production Comparison by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 22. Global Tofacitinib Citrate API Production (Tons) by Region (2020-2025)
 Table 23. Global Tofacitinib Citrate API Production Market Share by Region (2020-2025)
 Table 24. Global Tofacitinib Citrate API Production (Tons) Forecast by Region (2026-2031)
 Table 25. Global Tofacitinib Citrate API Production Market Share Forecast by Region (2026-2031)
 Table 26. Global Tofacitinib Citrate API Market Average Price (US$/Kg) by Region (2020-2025)
 Table 27. Global Tofacitinib Citrate API Market Average Price (US$/Kg) by Region (2026-2031)
 Table 28. Global Tofacitinib Citrate API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 29. Global Tofacitinib Citrate API Consumption by Region (2020-2025) & (Tons)
 Table 30. Global Tofacitinib Citrate API Consumption Market Share by Region (2020-2025)
 Table 31. Global Tofacitinib Citrate API Forecasted Consumption by Region (2026-2031) & (Tons)
 Table 32. Global Tofacitinib Citrate API Forecasted Consumption Market Share by Region (2026-2031)
 Table 33. North America Tofacitinib Citrate API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)
 Table 34. North America Tofacitinib Citrate API Consumption by Country (2020-2025) & (Tons)
 Table 35. North America Tofacitinib Citrate API Consumption by Country (2026-2031) & (Tons)
 Table 36. Europe Tofacitinib Citrate API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)
 Table 37. Europe Tofacitinib Citrate API Consumption by Country (2020-2025) & (Tons)
 Table 38. Europe Tofacitinib Citrate API Consumption by Country (2026-2031) & (Tons)
 Table 39. Asia Pacific Tofacitinib Citrate API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 40. Asia Pacific Tofacitinib Citrate API Consumption by Region (2020-2025) & (Tons)
 Table 41. Asia Pacific Tofacitinib Citrate API Consumption by Region (2026-2031) & (Tons)
 Table 42. Latin America, Middle East & Africa Tofacitinib Citrate API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)
 Table 43. Latin America, Middle East & Africa Tofacitinib Citrate API Consumption by Country (2020-2025) & (Tons)
 Table 44. Latin America, Middle East & Africa Tofacitinib Citrate API Consumption by Country (2026-2031) & (Tons)
 Table 45. Global Tofacitinib Citrate API Production (Tons) by Type (2020-2025)
 Table 46. Global Tofacitinib Citrate API Production (Tons) by Type (2026-2031)
 Table 47. Global Tofacitinib Citrate API Production Market Share by Type (2020-2025)
 Table 48. Global Tofacitinib Citrate API Production Market Share by Type (2026-2031)
 Table 49. Global Tofacitinib Citrate API Production Value (US$ Million) by Type (2020-2025)
 Table 50. Global Tofacitinib Citrate API Production Value (US$ Million) by Type (2026-2031)
 Table 51. Global Tofacitinib Citrate API Production Value Market Share by Type (2020-2025)
 Table 52. Global Tofacitinib Citrate API Production Value Market Share by Type (2026-2031)
 Table 53. Global Tofacitinib Citrate API Price (US$/Kg) by Type (2020-2025)
 Table 54. Global Tofacitinib Citrate API Price (US$/Kg) by Type (2026-2031)
 Table 55. Global Tofacitinib Citrate API Production (Tons) by Application (2020-2025)
 Table 56. Global Tofacitinib Citrate API Production (Tons) by Application (2026-2031)
 Table 57. Global Tofacitinib Citrate API Production Market Share by Application (2020-2025)
 Table 58. Global Tofacitinib Citrate API Production Market Share by Application (2026-2031)
 Table 59. Global Tofacitinib Citrate API Production Value (US$ Million) by Application (2020-2025)
 Table 60. Global Tofacitinib Citrate API Production Value (US$ Million) by Application (2026-2031)
 Table 61. Global Tofacitinib Citrate API Production Value Market Share by Application (2020-2025)
 Table 62. Global Tofacitinib Citrate API Production Value Market Share by Application (2026-2031)
 Table 63. Global Tofacitinib Citrate API Price (US$/Kg) by Application (2020-2025)
 Table 64. Global Tofacitinib Citrate API Price (US$/Kg) by Application (2026-2031)
 Table 65. Huateng Pharma Tofacitinib Citrate API Company Information
 Table 66. Huateng Pharma Tofacitinib Citrate API Specification and Application
 Table 67. Huateng Pharma Tofacitinib Citrate API Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 68. Huateng Pharma Main Business and Markets Served
 Table 69. Huateng Pharma Recent Developments/Updates
 Table 70. Beijing Mesochem Technology Tofacitinib Citrate API Company Information
 Table 71. Beijing Mesochem Technology Tofacitinib Citrate API Specification and Application
 Table 72. Beijing Mesochem Technology Tofacitinib Citrate API Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 73. Beijing Mesochem Technology Main Business and Markets Served
 Table 74. Beijing Mesochem Technology Recent Developments/Updates
 Table 75. CR Double-Crane Pharmaceuticals Tofacitinib Citrate API Company Information
 Table 76. CR Double-Crane Pharmaceuticals Tofacitinib Citrate API Specification and Application
 Table 77. CR Double-Crane Pharmaceuticals Tofacitinib Citrate API Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 78. CR Double-Crane Pharmaceuticals Main Business and Markets Served
 Table 79. CR Double-Crane Pharmaceuticals Recent Developments/Updates
 Table 80. Changzhou Pharmaceutical Factory Tofacitinib Citrate API Company Information
 Table 81. Changzhou Pharmaceutical Factory Tofacitinib Citrate API Specification and Application
 Table 82. Changzhou Pharmaceutical Factory Tofacitinib Citrate API Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 83. Changzhou Pharmaceutical Factory Main Business and Markets Served
 Table 84. Changzhou Pharmaceutical Factory Recent Developments/Updates
 Table 85. Chongqing Fuan Pharmaceutical Tofacitinib Citrate API Company Information
 Table 86. Chongqing Fuan Pharmaceutical Tofacitinib Citrate API Specification and Application
 Table 87. Chongqing Fuan Pharmaceutical Tofacitinib Citrate API Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 88. Chongqing Fuan Pharmaceutical Main Business and Markets Served
 Table 89. Chongqing Fuan Pharmaceutical Recent Developments/Updates
 Table 90. Sichuan Renan Pharmaceutical Tofacitinib Citrate API Company Information
 Table 91. Sichuan Renan Pharmaceutical Tofacitinib Citrate API Specification and Application
 Table 92. Sichuan Renan Pharmaceutical Tofacitinib Citrate API Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 93. Sichuan Renan Pharmaceutical Main Business and Markets Served
 Table 94. Sichuan Renan Pharmaceutical Recent Developments/Updates
 Table 95. Metrochem API Tofacitinib Citrate API Company Information
 Table 96. Metrochem API Tofacitinib Citrate API Specification and Application
 Table 97. Metrochem API Tofacitinib Citrate API Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 98. Metrochem API Main Business and Markets Served
 Table 99. Metrochem API Recent Developments/Updates
 Table 100. Dr. Reddy's Laboratories Tofacitinib Citrate API Company Information
 Table 101. Dr. Reddy's Laboratories Tofacitinib Citrate API Specification and Application
 Table 102. Dr. Reddy's Laboratories Tofacitinib Citrate API Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 103. Dr. Reddy's Laboratories Main Business and Markets Served
 Table 104. Dr. Reddy's Laboratories Recent Developments/Updates
 Table 105. Kekule Pharma Tofacitinib Citrate API Company Information
 Table 106. Kekule Pharma Tofacitinib Citrate API Specification and Application
 Table 107. Kekule Pharma Tofacitinib Citrate API Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 108. Kekule Pharma Main Business and Markets Served
 Table 109. Kekule Pharma Recent Developments/Updates
 Table 110. Apotex Pharmachem Tofacitinib Citrate API Company Information
 Table 111. Apotex Pharmachem Tofacitinib Citrate API Specification and Application
 Table 112. Apotex Pharmachem Tofacitinib Citrate API Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 113. Apotex Pharmachem Main Business and Markets Served
 Table 114. Apotex Pharmachem Recent Developments/Updates
 Table 115. Bulat Pharmaceutical Tofacitinib Citrate API Company Information
 Table 116. Bulat Pharmaceutical Tofacitinib Citrate API Specification and Application
 Table 117. Bulat Pharmaceutical Tofacitinib Citrate API Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 118. Bulat Pharmaceutical Main Business and Markets Served
 Table 119. Bulat Pharmaceutical Recent Developments/Updates
 Table 120. Delmar Chemicals Tofacitinib Citrate API Company Information
 Table 121. Delmar Chemicals Tofacitinib Citrate API Specification and Application
 Table 122. Delmar Chemicals Tofacitinib Citrate API Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 123. Delmar Chemicals Main Business and Markets Served
 Table 124. Delmar Chemicals Recent Developments/Updates
 Table 125. Glenmark Pharmaceuticals Tofacitinib Citrate API Company Information
 Table 126. Glenmark Pharmaceuticals Tofacitinib Citrate API Specification and Application
 Table 127. Glenmark Pharmaceuticals Tofacitinib Citrate API Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 128. Glenmark Pharmaceuticals Main Business and Markets Served
 Table 129. Glenmark Pharmaceuticals Recent Developments/Updates
 Table 130. Kukjeon Pharmaceutical Tofacitinib Citrate API Company Information
 Table 131. Kukjeon Pharmaceutical Tofacitinib Citrate API Specification and Application
 Table 132. Kukjeon Pharmaceutical Tofacitinib Citrate API Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 133. Kukjeon Pharmaceutical Main Business and Markets Served
 Table 134. Kukjeon Pharmaceutical Recent Developments/Updates
 Table 135. MSN Laboratories Tofacitinib Citrate API Company Information
 Table 136. MSN Laboratories Tofacitinib Citrate API Specification and Application
 Table 137. MSN Laboratories Tofacitinib Citrate API Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 138. MSN Laboratories Main Business and Markets Served
 Table 139. MSN Laboratories Recent Developments/Updates
 Table 140. Mylan Inc Tofacitinib Citrate API Company Information
 Table 141. Mylan Inc Tofacitinib Citrate API Specification and Application
 Table 142. Mylan Inc Tofacitinib Citrate API Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 143. Mylan Inc Main Business and Markets Served
 Table 144. Mylan Inc Recent Developments/Updates
 Table 145. Vitalpharms Tofacitinib Citrate API Company Information
 Table 146. Vitalpharms Tofacitinib Citrate API Specification and Application
 Table 147. Vitalpharms Tofacitinib Citrate API Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 148. Vitalpharms Main Business and Markets Served
 Table 149. Vitalpharms Recent Developments/Updates
 Table 150. Key Raw Materials Lists
 Table 151. Raw Materials Key Suppliers Lists
 Table 152. Tofacitinib Citrate API Distributors List
 Table 153. Tofacitinib Citrate API Customers List
 Table 154. Tofacitinib Citrate API Market Trends
 Table 155. Tofacitinib Citrate API Market Drivers
 Table 156. Tofacitinib Citrate API Market Challenges
 Table 157. Tofacitinib Citrate API Market Restraints
 Table 158. Research Programs/Design for This Report
 Table 159. Key Data Information from Secondary Sources
 Table 160. Key Data Information from Primary Sources
 Table 161. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Tofacitinib Citrate API
 Figure 2. Global Tofacitinib Citrate API Market Value by Type, (US$ Million) & (2020-2031)
 Figure 3. Global Tofacitinib Citrate API Market Share by Type: 2024 VS 2031
 Figure 4. 0.98 Product Picture
 Figure 5. 0.99 Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Tofacitinib Citrate API Market Value by Application, (US$ Million) & (2020-2031)
 Figure 8. Global Tofacitinib Citrate API Market Share by Application: 2024 VS 2031
 Figure 9. Tablets
 Figure 10. Others
 Figure 11. Global Tofacitinib Citrate API Production Value (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Tofacitinib Citrate API Production Value (US$ Million) & (2020-2031)
 Figure 13. Global Tofacitinib Citrate API Production Capacity (Tons) & (2020-2031)
 Figure 14. Global Tofacitinib Citrate API Production (Tons) & (2020-2031)
 Figure 15. Global Tofacitinib Citrate API Average Price (US$/Kg) & (2020-2031)
 Figure 16. Tofacitinib Citrate API Report Years Considered
 Figure 17. Tofacitinib Citrate API Production Share by Manufacturers in 2024
 Figure 18. Global Tofacitinib Citrate API Production Value Share by Manufacturers (2024)
 Figure 19. Tofacitinib Citrate API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. The Global 5 and 10 Largest Players: Market Share by Tofacitinib Citrate API Revenue in 2024
 Figure 21. Global Tofacitinib Citrate API Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 22. Global Tofacitinib Citrate API Production Value Market Share by Region: 2020 VS 2024 VS 2031
 Figure 23. Global Tofacitinib Citrate API Production Comparison by Region: 2020 VS 2024 VS 2031 (Tons)
 Figure 24. Global Tofacitinib Citrate API Production Market Share by Region: 2020 VS 2024 VS 2031
 Figure 25. North America Tofacitinib Citrate API Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 26. Europe Tofacitinib Citrate API Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 27. China Tofacitinib Citrate API Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 28. Japan Tofacitinib Citrate API Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 29. Global Tofacitinib Citrate API Consumption by Region: 2020 VS 2024 VS 2031 (Tons)
 Figure 30. Global Tofacitinib Citrate API Consumption Market Share by Region: 2020 VS 2024 VS 2031
 Figure 31. North America Tofacitinib Citrate API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 32. North America Tofacitinib Citrate API Consumption Market Share by Country (2020-2031)
 Figure 33. U.S. Tofacitinib Citrate API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 34. Canada Tofacitinib Citrate API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 35. Europe Tofacitinib Citrate API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 36. Europe Tofacitinib Citrate API Consumption Market Share by Country (2020-2031)
 Figure 37. Germany Tofacitinib Citrate API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 38. France Tofacitinib Citrate API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 39. U.K. Tofacitinib Citrate API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 40. Italy Tofacitinib Citrate API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 41. Russia Tofacitinib Citrate API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 42. Asia Pacific Tofacitinib Citrate API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 43. Asia Pacific Tofacitinib Citrate API Consumption Market Share by Region (2020-2031)
 Figure 44. China Tofacitinib Citrate API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 45. Japan Tofacitinib Citrate API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 46. South Korea Tofacitinib Citrate API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 47. China Taiwan Tofacitinib Citrate API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 48. Southeast Asia Tofacitinib Citrate API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 49. India Tofacitinib Citrate API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 50. Latin America, Middle East & Africa Tofacitinib Citrate API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 51. Latin America, Middle East & Africa Tofacitinib Citrate API Consumption Market Share by Country (2020-2031)
 Figure 52. Mexico Tofacitinib Citrate API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 53. Brazil Tofacitinib Citrate API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 54. Turkey Tofacitinib Citrate API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 55. GCC Countries Tofacitinib Citrate API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 56. Global Production Market Share of Tofacitinib Citrate API by Type (2020-2031)
 Figure 57. Global Production Value Market Share of Tofacitinib Citrate API by Type (2020-2031)
 Figure 58. Global Tofacitinib Citrate API Price (US$/Kg) by Type (2020-2031)
 Figure 59. Global Production Market Share of Tofacitinib Citrate API by Application (2020-2031)
 Figure 60. Global Production Value Market Share of Tofacitinib Citrate API by Application (2020-2031)
 Figure 61. Global Tofacitinib Citrate API Price (US$/Kg) by Application (2020-2031)
 Figure 62. Tofacitinib Citrate API Value Chain
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions